BASF and Bend Research collaborate to improve solubility and bioavailability of drugs

BASF says that it has signed an agreement with Bend Research (Bend, OR) to jointly evaluate and develop novel excipients to enhance the solubility and bioavailability of poorly soluble drugs. Bioavailability is the measure of the amount of drug that is actually absorbed from a given dose.  Bend Research is a company that provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its facilities, and advances promising drug candidates from conception through...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers